首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   266篇
  免费   7篇
化学   208篇
晶体学   4篇
力学   7篇
数学   19篇
物理学   35篇
  2022年   4篇
  2021年   4篇
  2017年   5篇
  2016年   4篇
  2015年   8篇
  2014年   2篇
  2013年   11篇
  2012年   15篇
  2011年   12篇
  2010年   8篇
  2009年   11篇
  2008年   14篇
  2007年   12篇
  2006年   12篇
  2005年   10篇
  2004年   4篇
  2003年   5篇
  2002年   7篇
  2000年   3篇
  1999年   3篇
  1997年   3篇
  1996年   4篇
  1995年   2篇
  1994年   5篇
  1993年   5篇
  1992年   3篇
  1991年   8篇
  1990年   7篇
  1989年   3篇
  1988年   3篇
  1987年   2篇
  1986年   5篇
  1985年   4篇
  1983年   3篇
  1982年   6篇
  1981年   3篇
  1980年   6篇
  1979年   5篇
  1978年   4篇
  1976年   3篇
  1975年   4篇
  1974年   2篇
  1973年   2篇
  1972年   2篇
  1971年   2篇
  1969年   3篇
  1963年   2篇
  1936年   3篇
  1928年   3篇
  1877年   2篇
排序方式: 共有273条查询结果,搜索用时 31 毫秒
1.
2.
3.
The recent development of an automated surface plasmon resonance technology for the measurement of biomolecular interactions (Pharmacia BIAcore) has provided new opportunities for the detection and analysis of protein-protein interactions. In the BIAcore, detection is based on changes in surface plasmon resonance which are monitored optically. Changes in surface plasmon resonance correspond to changes in surface concentration of macromolecules and can be monitored in real time.

We have found that the detection sensitivity obtainable with this technology (ng/ml concentrations of specific ligands are readily detectable for many applications) is complementary “in a bidirectional manner” to micropreparative HPLC. Thus micropreparative HPLC may be used to purify and characterise reagents for the biosensor, whilst the biosensor may be used to define chromatographic parameters such as elution conditions for affinity chromatography or serve as an affinity detector for fractions obtained during chromatographic purification.

Examples of such applications, including the potential of the biosensor to search for and monitor the purification of unknown ligands for which the target molecule has been identified, are shown. In particular, the use of the biosensor to monitor the purification of soluble epidermal growth factor receptor from A431 cell conditioned media is demonstrated.  相似文献   

4.
The transposition of oxirane-ethanols, through alkoxytin compounds, into oxetane-2-methanols and/or oxolan-3-ols (tetrahydrofuran-3-ols) is dependent upon the oxirane configuration. Cis configuration is more suitable for the formation of the smallest ring. Steric hindrance is not sufficient enough to explain the results.  相似文献   
5.
6.
Isomerization of Protonated Aldehyde and Ketone Ions in the Mass-Spectrography Before the Loss of Water In mass spectrometry, protonated aldehyde and ketone ions isomerize before the loss of a molecule of water. In order to specify this process, the spectra of deuterium labelled protonated aldehydes and ketones have been compared to the spectra of the corresponding isomer ions.  相似文献   
7.
A series of ferrocene derivatives based upon the structure of the antiestrogenic drug tamoxifen or of its active metabolite hydroxytamoxifen has been prepared and named by analogy ferrocifens and hydroxyferrocifens. This series includes 1-[4-(O(CH(2))(n)NMe(2))phenyl]-1-phenyl-2-ferrocenyl-but-1-ene and 1-[4-(-O(CH(2))(n)NMe(2))phenyl]-1-(4-hydroxyphenyl)-2-ferrocenyl-but-1-ene, with n=2, 3, 5 and 8, and 1-[4-(-O(CH(2))(2)NMe(2))phenyl]-1-(4-hydroxyphenyl)-2-ferrocenylethene. Most of these molecules have been synthesised by McMurry cross-coupling of the appropriate ketones, except for the ethene complexes, which were prepared by a four-step reaction sequence starting from the ferrocenylacetic acid. All these compounds were obtained as mixtures of Z and E isomers. The isomers were separated in the cases of the ferrocenyl derivatives of tamoxifen and hydroxytamoxifen (n=2). No isomerisation of the Z and E isomers occurred in DMSO after one day, while a 50:50 mixture of the isomers was obtained within one hour in chloroform. The X-ray structure of (E)-1-[4-(-O(CH(2))(2)NMe(2))phenyl]-1-(4-hydroxyphenyl)-2-ferrocenyl-but-1-ene has been determined. The relative binding affinity (RBA) values of the hydroxyferrocifens for the estrogen receptor alpha (ERalpha) was good to moderate, with values decreasing progressively with the length of the basic chain. The RBA values found for the estrogen receptor beta (ERbeta) are equal to or slightly less than those found for the alpha form. The lipophilicity of the hydroxyferrocifens are superior to the values found for estradiol and increase with lengthening of the chain. The antiproliferative effects of the four hydroxyferrocifens with n=2, 3, 5 and 8 were studied on four breast cancer cell lines (MCF7, MDA-MB231, RTx6 and TD5) possessing different levels of ERalpha. On MCF7 cells containing high levels of ERalpha, hydroxyferrocifens behave as antiestrogens. At a molarity of 1 microM the effect is close to that of hydroxytamoxifen (used for reference) when n=2 or 5, more marked when n=3, and weaker when n=8. Ferrocene alone has no effect. For the MDA-MB231 cells, classed as a hormone-independent breast cancer cell line, on the other hand, the hydroxyferrocifens show remarkable antiproliferative behaviour while the hydroxytamoxifen is completely inactive. Hydroxyferrocifens therefore show the unique property of being active both on hormone-dependent and on hormone-independent breast cancer cell lines. The molecular modelling study provides some clues for understanding of the antagonist effect of these molecules, while an additional cytotoxic effect due to the vectorised ferrocenyl unit is revealed in some occasions.  相似文献   
8.
9.
10.
Abstract— Quantum chemical calculations have been performed on the retinylidene Schiff base assumed to be protonated or hydrogen bonded at the nitrogen and perturbed by a carboxylate ion at its β-ionone end. The results indicate that weak charge transfer type bands might exist due to electron transfer from the carboxylate ion to the Schiff base and that the intense (π, π*) band in the visible spectrum might acquire a significant degree of charge transfer character.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号